Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1500
+0.0030 (2.04%)
At close: Mar 10, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Sales and Distribution of Medicines and Healthcare Products and Medical Devices
523.05M554.63M326.96M337.32M591.25M
Sales and Distribution of Medicines and Healthcare Products and Medical Devices Growth
-5.69%69.63%-3.07%-42.95%1.30%
Manufacturing and Selling of Medicines and Medical Devices
576.48M611.48M724.77M547.80M477.96M
Manufacturing and Selling of Medicines and Medical Devices Growth
-5.72%-15.63%32.31%14.61%-11.72%
Elimination of Inter-Segment
-57.83M-101.25M-65.05M-46.31M-37.84M
Total
1.04B1.06B986.69M838.81M1.03B
Total Growth
-2.18%7.92%17.63%-18.67%-4.58%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
People's Republic of China (PRC)
1.04B1.06B986.69M838.81M1.03B
People's Republic of China (PRC) Growth
-2.18%7.92%17.63%-18.67%-4.58%
Total
1.04B1.06B986.69M838.81M1.03B
Total Growth
-2.18%7.92%17.63%-18.67%-4.58%
Source: S&P Global Market Intelligence.